Catalyst Wire Dossier Catalyst Wire Dossier

fenfluramine hydrochloride (Fintepla)

fenfluramine hydrochloride · UCB BIOSCIENCES, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for fenfluramine hydrochloride (Fintepla), covering 2026-04-03 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Fenfluramine (Hydrochloride) in Infants 1 Year to Less Than 2 Years of Age With Dravet Syndrome [Phase 3]

See pricing